Human Papillomavirus Types 16 and 18 mRNA Levels and Not DNA Levels May be Associated With Advancing Stages of Cervical Cancer
- 1 November 2009
- journal article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 19 (8), 1415-1420
- https://doi.org/10.1111/igc.0b013e3181b62e05
Abstract
Human papillomavirus (HPV) contributes to the development of cervical cancer. We hypothesize that HPV DNA and messenger RNA (mRNA) levels may be associated with increasing stages of cervical cancer. In this study, we measured DNA and mRNA viral loads of the most common high-risk HPV-16 and HPV-18 in cervical biopsy tissue of women with cervical neoplasia using real-time polymerase chain reaction. Median HPV-16 and HPV-18 DNA viral loads were 58,342 copies and 71,367 per 5000 cells, respectively. We found that HPV-16 and HPV-18 DNA levels did not correlate with advancing tumor stage (P = 0.977 and P = 0.263). Messenger RNA transcripts were detected in 81 (86%) of HPV-16 DNA-positive women and in 16 (84.2%) of HPV-18-positive women. Median HPV-16 and HPV-18 transcript copy numbers were 5964 and 6158, respectively. In women with squamous cell carcinoma, HPV-16 mRNA loads showed an increasing but not statistically significant trend with advancing disease stage (rho = 0.231, P = 0.058). We conclude that HPV mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.Keywords
This publication has 13 references indexed in Scilit:
- Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesionsInternational Journal of Gynecologic Cancer, 2008
- HPV prevalence, viral load and physical state of HPV‐16 in cervical smears of patients with different grades of CINInternational Journal of Cancer, 2007
- Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimensInfectious Agents and Cancer, 2007
- High Human Papillomavirus Oncogene mRNA Expression and Not Viral DNA Load Is Associated with Poor Prognosis in Cervical Cancer PatientsClinical Cancer Research, 2007
- Viral Load, E2 Gene Disruption Status, and Lineage of Human Papillomavirus Type 16 Infection in Cervical NeoplasiaThe Journal of Infectious Diseases, 2006
- Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)British Journal of Cancer, 2005
- Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoringJournal of Medical Virology, 2004
- Human Papillomavirus 16 E6/E7 Transcript and E2 Gene Status in Patients with Cervical NeoplasiaMolecular Diagnosis, 2004
- Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real‐time polymerase chain reaction analysisCancer, 2002
- Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control studyThe Lancet, 2000